The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
(Page 2 of 2)
Current implanted glucose sensors require inserting an electrode under the skin; a metal wire connects the electrode to a monitoring device. The electrode has to be held in place with an adhesive tape. However, such devices can quickly cause infection and must be replaced every three days, which can get expensive. "They are looked upon as a foreign body, a splinter, and the body tries to reject them," says George Wilson, a chemistry professor involved in biosensor research at the University of Kansas.
Loeb says that it should be possible to leave his glucose-sensing fiber inside human skin for a few months. He has implanted his fiber in pigs for up to three months without causing an inflammation.
So far, Loeb has tested his fiber-optic system in glucose solutions and has found that it is sensitive to the range of glucose concentrations that are found in the human body. But the system's response inside living animals will be crucial to letting researchers know if it works. "There is an enormous difference between a sensor that operates in solution and a sensor that operates in animals," Wilson says.
Once the optical glucose sensor is tested in animals, it would need to go through clinical trials, which can take four to five years. If everything goes as planned, both Loeb and Cote believe that their sensors could be available as products in five to ten years.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
Our list of the 50 most innovative companies, including the following: